Non-surgical management of recurrent Paget’s disease of the vulva: A case report

Paget's Disease of the Vulva is a relatively rare condition with a high rate of recurrence. Extensive work-up and treatment is warranted as lesions have the capacity to become invasive and can be associated with underlying malignancy. First line therapy includes surgical resection. For those that are not surgical candidates or who do not desire surgical intervention, non-surgical management options include topical therapy with imiquimod. Unfortunately, irritating side effects often results in poor treatment compliance and premature discontinuation limiting efficacy. Here we present a unique case of extensive, recurrent vulvar Paget's disease with excellent response to a combination therapy of imiquimod and Silver Sulfadiazine. To the best of our knowledge, this is the first documented case illustrating the utility of non-surgical management with combination therapy with topical imiquimod and Silver Sulfadiazine for treatment in patients who do not desire surgical intervention.

Authors

Institutions

Publication Details

Journal
Gynecologic Oncology Reports
Published
2024-09-17
DOI
https://doi.org/10.1016/j.gore.2024.101511
Citations
1
Primary Topic
Cancer and Skin Lesions
Type
article
Field-Weighted Citation Impact
0.53
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-surgical management of recurrent Paget’s disease of the vulva: A case report

Floor Jenniskens Backes, Hannah Kennedy, Emily Coffey-Noriega
1 citations
Gynecologic Oncology Reports
Cancer and Skin Lesions
0.53
article

Non-surgical management of recurrent Paget’s disease of the vulva: A case report

Floor Jenniskens Backes, Hannah Kennedy, Emily Coffey-Noriega
article en
1 citations

Abstract

Paget's Disease of the Vulva is a relatively rare condition with a high rate of recurrence. Extensive work-up and treatment is warranted as lesions have the capacity to become invasive and can be associated with underlying malignancy. First line therapy includes surgical resection. For those that are not surgical candidates or who do not desire surgical intervention, non-surgical management options include topical therapy with imiquimod. Unfortunately, irritating side effects often results in poor treatment compliance and premature discontinuation limiting efficacy. Here we present a unique case of extensive, recurrent vulvar Paget's disease with excellent response to a combination therapy of imiquimod and Silver Sulfadiazine. To the best of our knowledge, this is the first documented case illustrating the utility of non-surgical management with combination therapy with topical imiquimod and Silver Sulfadiazine for treatment in patients who do not desire surgical intervention.

Gynecologic Oncology ReportsVol. 55
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), The Ohio State University Wexner Medical Center (US)
Openalex Percentile: Top 28%
Cancer and Skin Lesions
0.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Non-surgical management of recurrent Paget’s disease of the vulva: A case report — Floor Jenniskens Backes, Hannah Kennedy, et al. · Gynecologic Oncology Reports (2024) | TGRS Research Map | TGRS